We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ingevity's (NGVT) Earnings and Sales Beat Estimates in Q1
Read MoreHide Full Article
Ingevity Corporation (NGVT - Free Report) logged profits of $48.7 million or $1.20 per share in first-quarter 2021, up around 8% from $45.3 million or $1.08 per share a year ago.
Adjusted earnings per share for the reported quarter were $1.27, surpassing the Zacks Consensus Estimate of $1.07.
The company’s revenues rose around 11% year over year to $320.3 million in the quarter. The top line also beat the Zacks Consensus Estimate of $293 million. The company benefited, in the first quarter, from higher demand across its businesses. It saw a strong rise in automotive-based activated carbon sales and a significant growth in engineered polymers across several applications.
Adjusted EBITDA went up around 14% year over year to $105.4 million in the quarter.
Ingevity Corporation Price, Consensus and EPS Surprise
Revenues from the Performance Chemicals division rose around 8% year over year to $179.6 million in the quarter under review. The company witnessed strong sales growth in engineered polymers and modest rise in industrial specialties and pavement technologies sales.
Revenues from the Performance Materials unit climbed 16% year over year to $140.7 million. Strong global automotive sales drove growth for the company’s activated carbon products used in gasoline vapor emission control systems.
Balance Sheet
Ingevity ended the quarter with cash and cash equivalents of $237.8 million, down roughly 21% year over year. Long-term debt was $1,263.1 million, down around 14% year over year.
Outlook
The company raised its outlook for sales for 2021 to $1.275-$1.325 billion from $1.25-$1.30 billion expected earlier. It also now anticipates adjusted EBITDA of $410-$430 million, up from the prior view of $400-$420 million.
Price Performance
Shares of Ingevity have gained 68.8% in the past year against the industry’s growth of 32.4%.
Zacks Rank & Key Picks
Ingevity currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks worth considering in the basic materials space include Nucor Corporation (NUE - Free Report) , Dow Inc. (DOW - Free Report) and Impala Platinum Holdings Limited (IMPUY - Free Report) .
Nucor has a projected earnings growth rate of 228.4% for the current year. The company’s shares have rallied around 92% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Dow has a projected earnings growth rate of 261.5% for the current year. The company’s shares have shot up around 69% in a year. It currently sports a Zacks Rank #1.
Impala Platinum has an expected earnings growth rate of 197.6% for the current fiscal. The company’s shares have surged around 225% in the past year. It currently carries a Zacks Rank #1.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
Image: Bigstock
Ingevity's (NGVT) Earnings and Sales Beat Estimates in Q1
Ingevity Corporation (NGVT - Free Report) logged profits of $48.7 million or $1.20 per share in first-quarter 2021, up around 8% from $45.3 million or $1.08 per share a year ago.
Adjusted earnings per share for the reported quarter were $1.27, surpassing the Zacks Consensus Estimate of $1.07.
The company’s revenues rose around 11% year over year to $320.3 million in the quarter. The top line also beat the Zacks Consensus Estimate of $293 million. The company benefited, in the first quarter, from higher demand across its businesses. It saw a strong rise in automotive-based activated carbon sales and a significant growth in engineered polymers across several applications.
Adjusted EBITDA went up around 14% year over year to $105.4 million in the quarter.
Ingevity Corporation Price, Consensus and EPS Surprise
Ingevity Corporation price-consensus-eps-surprise-chart | Ingevity Corporation Quote
Segment Review
Revenues from the Performance Chemicals division rose around 8% year over year to $179.6 million in the quarter under review. The company witnessed strong sales growth in engineered polymers and modest rise in industrial specialties and pavement technologies sales.
Revenues from the Performance Materials unit climbed 16% year over year to $140.7 million. Strong global automotive sales drove growth for the company’s activated carbon products used in gasoline vapor emission control systems.
Balance Sheet
Ingevity ended the quarter with cash and cash equivalents of $237.8 million, down roughly 21% year over year. Long-term debt was $1,263.1 million, down around 14% year over year.
Outlook
The company raised its outlook for sales for 2021 to $1.275-$1.325 billion from $1.25-$1.30 billion expected earlier. It also now anticipates adjusted EBITDA of $410-$430 million, up from the prior view of $400-$420 million.
Price Performance
Shares of Ingevity have gained 68.8% in the past year against the industry’s growth of 32.4%.
Zacks Rank & Key Picks
Ingevity currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks worth considering in the basic materials space include Nucor Corporation (NUE - Free Report) , Dow Inc. (DOW - Free Report) and Impala Platinum Holdings Limited (IMPUY - Free Report) .
Nucor has a projected earnings growth rate of 228.4% for the current year. The company’s shares have rallied around 92% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Dow has a projected earnings growth rate of 261.5% for the current year. The company’s shares have shot up around 69% in a year. It currently sports a Zacks Rank #1.
Impala Platinum has an expected earnings growth rate of 197.6% for the current fiscal. The company’s shares have surged around 225% in the past year. It currently carries a Zacks Rank #1.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
See the 5 high-tech stocks now>>